Pharmaceutical Manufacturing Handbook: Production and

434 BIODEGRADABLE POLYMER-BASED MICROSPHERES
112. Men , Y. , Audran , R. , Thomasin , C. , Eberl , G. , Demotz , S. , Merkle , H. P. , Gander , B. , and
Corradin , G. ( 1999 ), MHC class I - and class II - restricted processing and presentation of
microencapsulated antigens , Vaccine , 17 , 1047 – 1056 .
113. Raychaudhuri , S. , and Rock , K. L. ( 1998 ), Fully mobilizing host defense: Building better
vaccines , Nat. Biotechnol ., 16 , 1025 – 1031 .
114. Visscher , G. E. , Robinson , R. L. , and Argentieri , G. J. ( 1987 ), Tissue response t biodegradable
injectable microcapsules , J. Biomater. Applic ., 2 , 118 – 131 .
115. Cleland , J. L. , Powell , M. F. , and Shire , S. J. ( 1993 ), The development of stable protein
formulations: A close look at protein aggregation, deamidation, and oxidation , Crit. Rev.
Therap. Drug Carrier Syst ., 10 , 307 – 377 .
116. Gupta , R. K. , Alroy , J. , Alonso , M. J. , Langer , R. , and Siber , G. R. ( 1997 ), Chronic tissue
reactions, long term immunogenicity and immunological priming of mice and guinea
pigs to tetanus toxoids encapsulated in biodegradable polymer microspheres composed
of polylactide -co - glycolide polymers , Vaccine , 15 , 1716 – 1723 .
117. Jiang , W. , Gupta , R. K. , Deshpande , M. C. , and Schwendeman , S. P. ( 2005 ), Biodegradable
poly(lactic -co - glycolic acid) microparticles for injectable delivery of vaccine antigens ,
Adv. Drug Deliv. Rev ., 57 , 391 – 410 .
118. Johnson , O. L. , and Tracy , M. A. ( 1999 ), Peptide and protein drug delivery , in Mathiowitz ,
E. , Ed., Encyclopedia of Controlled Drug Delivery , Vol. 2, Wiley , New York , pp.
816 – 833 .
119. Braun , A. , and Alsenz , J. ( 1997 ), Development and use of enzyme - linked immunosorbent
assays (ELISA) for the detection of protein aggregates in interferon - alpha (IFN -
alpha) formulations , Pharm. Res ., 14 , 1394 – 1400 .
120. Hochuli , E. ( 1997 ), Interferon immunogenicity: Technical evaluation of interferon - alpha
2a , J. Interferon Cytokine Res ., 17 ( Suppl 1 ), 15 – 21 .
121. Volkin , D. B. , and Middaugh , C. R. ( 1992 ), in: Ahern , T. J. , Manning , M. C. , Eds., Stability
of Protein Pharmaceuticals Part A: Chemical and Physical Pathways of Protein Degradation
, Plenum , New York , pp. 109 – 134 .
122. Manning , M. C. , Patel , K. , and Borchardt , R. T. ( 1989 ), Stability of protein pharmaceuticals
, Pharm. Res ., 6 , 903 – 918 .
123. Zale , S. E. , and Klibanov , A. M. ( 1986 ), Why does ribonuclease irreversibly inactivate at
high temperatures? Biochemistry , 25 , 5432 – 5443 .
124. Jiang , W. , and Schwendeman , S. P. ( 2000 ), Formaldehyde - mediated aggregation of protein
antigens: Comparison of untreated and formalinized model antigens , Biotechnol. Bioeng .,
70 , 507 – 517 .
125. Jiang , W. , and Schwendeman , S. P. ( 2001 ), Stabilization of a model formalinized protein
antigen encapsulated in poly(lactide -co - glycolide) - based microspheres , J. Pharm. Sci .,
90 , 1558 – 1569 .
126. Zhu , G. , Mallery , S. R. , and Schwendeman , S. P. ( 2000 ), Stabilization of proteins encapsulated
in injectable poly(lactide -co - glycolide) , Nat. Biotechnol ., 18 , 52 – 57 .
127. Schwendeman , S. P. , Cardamone , M. , Klibanov , A. , and Langer , R. ( 1996 ), Stability of
proteins and their delivery from biodegradable polymer microspheres , in Cohen , S. , and
Bernstein , H. , Eds., Microparticulates Systems for the Delivery of Proteins and Vaccines ,
Marcel Dekker , New York , pp. 1 – 49 .
128. van de Weert , M. , Hennink , W. E. , and Jiskoot , W. ( 2000 ), Protein instability in poly(lactic -
co - glycolic acid) microparticles , Pharm. Res ., 17 , 1159 – 1167 .
129. Schwendeman , S. P. ( 2002 ), Recent advances in the stabilization of proteins encapsulated
in injectable PLGA delivery systems , Crit. Rev. Therap. Drug Carrier Syst ., 19 , 73 –
98 .